.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Novartis
Healthtrust
Daiichi Sankyo
Deloitte
UBS
Chubb
Boehringer Ingelheim
Fuji
US Army

Generated: September 23, 2017

DrugPatentWatch Database Preview

Eflornithine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for eflornithine hydrochloride and what is the scope of eflornithine hydrochloride freedom to operate?

Eflornithine hydrochloride
is the generic ingredient in two branded drugs marketed by Skinmedica and Sanofi Aventis Us, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for eflornithine hydrochloride. Two suppliers are listed for this compound.

Summary for Generic Name: eflornithine hydrochloride

Tradenames:2
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list43
Clinical Trials: see list2,299
Patent Applications: see list27
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:eflornithine hydrochloride at DailyMed

Pharmacology for Ingredient: eflornithine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
ORNIDYL
eflornithine hydrochloride
INJECTABLE;INJECTION019879-002Nov 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Skinmedica
VANIQA
eflornithine hydrochloride
CREAM;TOPICAL021145-001Jul 27, 2000RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: eflornithine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Skinmedica
VANIQA
eflornithine hydrochloride
CREAM;TOPICAL021145-001Jul 27, 2000► Subscribe► Subscribe
Sanofi Aventis Us
ORNIDYL
eflornithine hydrochloride
INJECTABLE;INJECTION019879-002Nov 28, 1990► Subscribe► Subscribe
Sanofi Aventis Us
ORNIDYL
eflornithine hydrochloride
INJECTABLE;INJECTION019879-002Nov 28, 1990► Subscribe► Subscribe
Skinmedica
VANIQA
eflornithine hydrochloride
CREAM;TOPICAL021145-001Jul 27, 2000► Subscribe► Subscribe
Skinmedica
VANIQA
eflornithine hydrochloride
CREAM;TOPICAL021145-001Jul 27, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Cantor Fitzgerald
Accenture
Fish and Richardson
Citi
Johnson and Johnson
Farmers Insurance
Cipla
Teva
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot